We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$297M
AUM Growth
+$56.9M
Cap. Flow
+$55.4M
Cap. Flow %
18.67%
Top 10 Hldgs %
80.3%
Holding
232
New
27
Increased
80
Reduced
67
Closed
26

Sector Composition

Rank Sector Weight
1 Real Estate 18.29%
2 Healthcare 13.15%
3 Technology 2%
4 Industrials 1.37%
5 Consumer Discretionary 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALBO
226
DELISTED
Albireo Pharma Inc
ALBO
-1,000
Closed -$38K
AERI
227
DELISTED
Aerie Pharmaceuticals
AERI
-4,000
Closed -$54K
ODT
228
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
-29,594
Closed -$568K
GWPH
229
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-1,150
Closed -$133K
PAND
230
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
-9,000
Closed -$134K
VIE
231
DELISTED
Viela Bio, Inc. Common Stock
VIE
-1,500
Closed -$54K
MUS
232
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
-2,050
Closed -$27K

Similar funds

AlphaCentric Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, AlphaCentric Advisors held 232 positions worth $297M, up 24% from $240M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

AlphaCentric Advisors deployed $55.4M of net new capital in Q1 2021, opening 27 new positions and adding to 80 existing holdings. Its largest new stake was Luminar Technologies: 3,333 shares worth $1.22M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Omnicell, an estimated $641K trimmed.

  • AlphaCentric Advisors's largest Q1 2021 buy was Luminar Technologies: 3,333 shares worth $1.22M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q1 2021, an estimated $25.2M increase.
  • AlphaCentric Advisors's biggest Q1 2021 reduction was Omnicell, cutting an estimated $641K.
  • AlphaCentric Advisors fully exited Globus Medical in Q1 2021, selling an estimated $978K.
  • AlphaCentric Advisors's ten largest holdings make up 80% of its $297M portfolio in Q1 2021.
  • AlphaCentric Advisors opened 27 new positions and closed 26 in Q1 2021.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $297M.

Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.